This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing "Intratympanic Administration of OTO-313 Reduces Tinnitus in Patients With Moderate to Severe, Persistent Tinnitus: A Phase 1/2 Study" With a Paper Author

Ticker(s): OTIC

Who's the expert?

Institution: University of Auckland

  • Associate Professor in the Audiology Section and directs the University of Auckland's Hearing and Tinnitus Clinic
  • Associate editor for the International Journal of Audiology, Journal of the American Academy of Audiology and Scientific Reports 
  • Author on the paper: "Intratympanic Administration of OTO-313 Reduces Tinnitus in Patients With Moderate to Severe, Persistent Tinnitus: A Phase 1/2 Study"

Interview Goal
This conversation will explore the findings of the Phase 1/2 study and potential of OTO-313 in treating Tinnitus.

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.